Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (38)
  • Autophagy
    (15)
  • Epigenetic Reader Domain
    (10)
  • DNA/RNA Synthesis
    (9)
  • PROTACs
    (9)
  • Akt
    (7)
  • Androgen Receptor
    (7)
  • TRP/TRPV Channel
    (7)
  • Caspase
    (6)
  • Others
    (74)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FACS
    (1)
  • Functional assay
    (1)
Filter
Search Result
Results for "

PC3

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    170
    TargetMol | All_Pathways
  • Peptide Products
    7
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    11
    TargetMol | PROTAC
  • Natural Products
    21
    TargetMol | Natural_Products
  • Recombinant Protein
    23
    TargetMol | Recombinant_Protein
  • Isotope Products
    3
    TargetMol | Isotope_Products
  • Antibody Products
    19
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • ADC/ADC Related
    4
    TargetMol | All_Pathways
Abacavir
Ziagen, Epzicom
T1267136470-78-5
Abacavir (Ziagen) is a nucleoside reverse transcriptase inhibitor analog of guanosine. This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Dasatinib
BMS-354825
T1448302962-49-8
Dasatinib (BMS-354825) is an orally active, ATP-competitive tyrosine kinase inhibitor that targets Src and Bcr-Abl (Ki=16/30 pM), with antitumor activity, used in the treatment of leukemia and lymphoma.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
Dasatinib monohydrate
BMS-354825 Monohydrate
T1448L863127-77-9
Dasatinib monohydrate (BMS-354825 Monohydrate) is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib monohydrate binds to and inhibits the growth-promoting activities of these kinases. Apparently, because of its less stringent binding affinity for the BCR-ABL kinase, Dasatinib monohydrate has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
Abacavir sulfate
Ziagen, ABC sulfate, Abacavir Hemisulfate, 1592U89
T6367188062-50-2
Abacavir sulfate (Ziagen) , a nucleoside analogue, effectively utilize its antiviral activity
  • $30
In Stock
Size
QTY
RHPS4
NSC714187
T6967390362-78-4
RHPS4 (RHPS 4 methosulfate) is a potent inhibitor of Telomerase at submicromolar.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Podophyllotoxone
T8188477-49-6
Podophyllotoxinone, a natural compound found in Dysosma versipellis, shows inhibitory activity against L1210 leukemia and KB cells in vitro.
  • $30
In Stock
Size
QTY
Periplocymarin
TN205432476-67-8
Periplocymarin is a cardiac glycoside with anticancer potential isolated from Periploca sepium and Periploca graeca.
  • $97
In Stock
Size
QTY
trans-C75
(±)-C75
T10656191282-48-1
trans-C75 ((±)-C75) is an enantiomer of C75, which is an inhibitor of fatty-acid synthase (FASN).
  • $44
In Stock
Size
QTY
C75
C-75
T10657218137-86-1
C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).C75 increases CPT1 activity and reduces DIO.
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
VPC32183
VPC-32183, VPC 32183
T29113717110-61-7
VPC32183 is a competitive antagonist of LPA1 and LPA3 receptors.
  • $1,820
8-10 weeks
Size
QTY
VPC32179
VPC-32179, VPC 32179
T35071799268-76-1
VPC32179 is a bioactive chemical.
  • $1,520
Inquiry
Size
QTY
TRPC3/6-IN-1
T61407736945-96-3
TRPC3/6-IN-1 is a highly potent and selective inhibitor that blocks the activity of canonical transient receptor channels TRPC3 and TRPC6, showing significant potency against human isoforms hTRPC3 and hTRPC6 with IC50 values of 1260 nM and 500 nM, respectively. This compound is valuable for research on chronic models of heart failure [1].
  • $120
35 days
Size
QTY
TRPC3/6-IN-2
T790542387893-55-0
TRPC3/6-IN-2 is a potent inhibitor of TRPC3 and TRPC6, with IC50 values of 16 nM and 29.8 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Anti-GPC3 Antibody (YP7)
T9901A-176
Anti-GPC3 Antibody (YP7) is a chimeric mouse IgG1, κ antibody that specifically targets human GPC3. The recommended isotype control for Anti-GPC3 Antibody (YP7) is Mouse IgG1 kappa, Isotype Control.
  • Inquiry Price
Inquiry
Size
QTY
GPC3 targeting peptide 1
TP30513066113-41-2
GPC3 targeting peptide 1 is a synthetic peptide ligand that binds to glypican-3 (GPC3) with a high affinity dissociation constant (Kd) of 0.23 nM. GPC3 targeting peptide 1 serves as a precise molecular probe for detecting and targeting GPC3-expressing tumor cells, particularly in hepatocellular carcinoma research, facilitating targeted imaging and therapeutic applications.
  • $608
7-10 days
Size
QTY
GPC3 targeting peptide 1 TFA
TP3744
GPC3 targeting peptide 1 TFA binds with GPC3, exhibiting a dissociation constant (Kd) of 0.23 nM.
  • Inquiry Price
Inquiry
Size
QTY
Phytochelatin 3
PC 3
T8147986220-45-3
Phytochelatin 3 (PC3) is a glutathione-derived peptide and heavy metal detoxifier/chelator consisting of 3 units of glu-cys.
  • $30
Inquiry
Size
QTY
Supinoxin
RX-5902
T16961888478-45-3
Supinoxin (RX-5902) is an orally active inhibitor of phosphorylated-p68 RNA helicase and a potent first-in-class anti-cancer agent, inducing cell apoptosis and inhibiting the growth of TNBC cancer cell lines (IC50s: 10 nM - 20 nM).
  • $115
In Stock
Size
QTY
CCG-1423
CCG1423
T2014285986-88-1
CCG-1423, a selective RhoA pathway inhibitor, suppresses SRF-mediated transcription.
  • $32
In Stock
Size
QTY
TargetMol | Citations Cited
SNS-314 Mesylate
SNS-314
T26171146618-41-8
SNS-314 Mesylate (SNS-314) is an effective and specific Aurora A/B/C inhibitor (IC50: 9/31/3 nM). It is less inhibition of Trk A/B, Fms, Flt4, c-Raf, Axl, and DDR2.
  • $33
In Stock
Size
QTY
CCG-203971
CCG203971
T43061443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
  • $48
In Stock
Size
QTY
Gemcitabine
NSC 613327, LY188011
T025195058-81-4
Gemcitabine (LY188011) is a synthetic cytosine nucleoside derivative and an inhibitor of DNA synthesis. Gemcitabine has antitumor and antimetabolic activities. Gemcitabine induces autophagy and apoptosis.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
(-)-Epigallocatechin Gallate
Epigallocatechol Gallate, EGCG
T2988989-51-5
(-)-Epigallocatechin Gallate (EGCG) is a phenolic antioxidant polyphenol flavonoid found in plants such as green and black tea, which inhibits telomerase and DNA methyltransferase, blocks the activation of EGF receptors and HER-2 receptors, inhibits cellular oxidation, and prevents free radical damage to cells.
  • $43
In Stock
Size
QTY
TargetMol | Citations Cited
Enzalutamide
MDV3100
T6002915087-33-1
Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist (IC50=36 nM in LNCaP) that activates autophagy, exhibits antitumor activity, and is commonly used in treating desmoplasia-resistant prostate cancer.
  • $40
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited